【9992】理研グリーン
〔上場廃止〕
ー(上場廃止)緑化薬剤販売
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019.10 | 2019/06/07 | Q2予 | 12,100 | → | 0.0% | 0.0% | 375 | → | 0.0% | 0.0% | 394 | → | 0.0% | 0.0% | 220 | → | 0.0% | 0.0% |
2019.10 | 2019/03/08 | Q1予 | 12,100 | → | 0.0% | 0.0% | 375 | → | 0.0% | 0.0% | 394 | → | 0.0% | 0.0% | 220 | → | 0.0% | 0.0% |
2019.10 | 2018/12/14 | 当初予 | 12,100 | - | - | - | 375 | - | - | - | 394 | - | - | - | 220 | - | - | - |
2018.10 | 2018/12/14 | 実 | 12,024 | ↑ | +0.0% | +1.0% | 524 | ↑ | +0.8% | +34.4% | 548 | ↑ | +0.6% | +37.0% | 434 | ↑ | +0.9% | +128.4% |
2018.10 | 2018/12/12 | 修正予 | 12,020 | ↑ | +1.0% | +1.0% | 520 | ↑ | +33.3% | +33.3% | 545 | ↑ | +36.3% | +36.3% | 430 | ↑ | +53.6% | +126.3% |
2018.10 | 2018/09/07 | Q3予 | 11,900 | → | 0.0% | 0.0% | 390 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% | 280 | → | 0.0% | +47.4% |
2018.10 | 2018/06/13 | Q2予 | 11,900 | → | 0.0% | 0.0% | 390 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% | 280 | → | 0.0% | +47.4% |
2018.10 | 2018/06/01 | 修正予 | 11,900 | → | 0.0% | 0.0% | 390 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% | 280 | ↑ | +47.4% | +47.4% |
2018.10 | 2018/03/12 | Q1予 | 11,900 | → | 0.0% | 0.0% | 390 | → | 0.0% | 0.0% | 400 | → | 0.0% | 0.0% | 190 | → | 0.0% | 0.0% |
2018.10 | 2017/12/14 | FY予 | 11,900 | - | - | - | 390 | - | - | - | 400 | - | - | - | 190 | - | - | - |
2018.03 | 2017/05/12 | 当初予 | 6,900 | - | - | - | 250 | - | - | - | 260 | - | - | - | 130 | - | - | - |
2017.10 | 2017/12/14 | 実 | 7,281 | ↑ | +0.0% | +5.5% | 495 | ↑ | +1.0% | +98.0% | 507 | ↑ | +1.4% | +95.0% | 438 | ↓ | -0.5% | +236.9% |
2017.10 | 2017/12/07 | 修正予 | 7,280 | ↑ | +5.5% | +5.5% | 490 | ↑ | +96.0% | +96.0% | 500 | ↑ | +92.3% | +92.3% | 440 | ↑ | +238.5% | +238.5% |
2017.10 | 2017/08/10 | 当初予 | 6,900 | - | - | - | 250 | - | - | - | 260 | - | - | - | 130 | - | - | - |
2017.03 | 2017/05/12 | 実 | 11,632 | ↓ | -1.4% | -1.4% | 337 | ↑ | +2.1% | +2.1% | 348 | ↑ | +2.4% | +2.4% | 145 | ↑ | +3.6% | +3.6% |
2017.03 | 2017/02/10 | Q3予 | 11,800 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 140 | → | 0.0% | 0.0% |
2017.03 | 2016/11/11 | Q2予 | 11,800 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 140 | → | 0.0% | 0.0% |
2017.03 | 2016/08/10 | Q1予 | 11,800 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 140 | → | 0.0% | 0.0% |
2017.03 | 2016/05/13 | 当初予 | 11,800 | - | - | - | 330 | - | - | - | 340 | - | - | - | 140 | - | - | - |
2016.03 | 2016/05/13 | 実 | 11,564 | ↓ | -2.0% | -2.0% | 314 | ↓ | -4.8% | -4.8% | 332 | ↑ | +0.6% | +0.6% | 253 | ↑ | +10.0% | +80.7% |
2016.03 | 2016/02/10 | Q3予 | 11,800 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 230 | → | 0.0% | +64.3% |
2016.03 | 2015/11/13 | Q2予 | 11,800 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 230 | → | 0.0% | +64.3% |
2016.03 | 2015/08/11 | Q1予 | 11,800 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 230 | → | 0.0% | +64.3% |
2016.03 | 2015/08/10 | 修正予 | 11,800 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 330 | → | 0.0% | 0.0% | 230 | ↑ | +64.3% | +64.3% |
2016.03 | 2015/05/15 | 当初予 | 11,800 | - | - | - | 330 | - | - | - | 330 | - | - | - | 140 | - | - | - |
2015.03 | 2015/05/15 | 実 | 11,447 | ↓ | -3.8% | -3.8% | 327 | ↓ | -3.8% | -3.8% | 325 | ↓ | -4.4% | -4.4% | 128 | ↓ | -8.6% | -8.6% |
2015.03 | 2015/02/13 | Q3予 | 11,900 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 140 | → | 0.0% | 0.0% |
2015.03 | 2014/11/14 | Q2予 | 11,900 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 140 | → | 0.0% | 0.0% |
2015.03 | 2014/08/08 | Q1予 | 11,900 | → | 0.0% | 0.0% | - | - | - | - | 340 | → | 0.0% | 0.0% | 140 | → | 0.0% | 0.0% |
2015.03 | 2014/05/15 | 当初予 | 11,900 | - | - | - | 340 | - | - | - | 340 | - | - | - | 140 | - | - | - |
2014.03 | 2014/05/15 | 実 | 11,455 | - | - | - | 304 | - | - | - | 310 | - | - | - | 121 | - | - | - |